John C. Pepia - 29 Oct 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role: Principal Accounting Officer
Signature: /s/ Dominic J. Andreano, Attorney-in-Fact
Issuer symbol: MD
Transactions as of: 29 Oct 2021
Net transactions value: -$248,225
Form type: 4
Filing time: 29 Oct 2021, 16:46:14 UTC
Previous filing: 03 Sep 2021
Next filing: 10 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	$248,225	-9,238	-8.3%	$26.87	101,666	29 Oct 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.83 to $26.94 for a weighted average sales price of $26.87. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Includes 61 shares acquired by the reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filing.

Content

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.83 to $26.94 for a weighted average sales price of $26.87. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 61 shares acquired by the reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filing.